ARTICLES BY THIS AUTHOR
- 4/27/2020
Amphastar receives FDA nod for generic Adrenalin
Adrenalin has a market value of roughly $131 million for the 12 months ended Dec. 31, 2019, according to IQVIA. - 4/27/2020
Industry orgs praise NY, Florida governors
NCPA and NACDS praised New York Gov. Andrew Cuomo for enlisting pharmacies to serve as COVID-19 testing collection centers. NACDS also lauded Florida Gov. Ron DeSantis' efforts. - 4/27/2020
Teva launches Ajovy auto-injector device
Teva's Ajovy injection offers quarterly or monthly dosing options for migraine patients. - 4/27/2020
Walgreens’ Red Nose Day takes on digital format
Walgreens is going digital with its sixth annual Red Nose Day fundraiser, which looks to help end child poverty. - 4/27/2020
Second Source Rx earns NABP Drug Distributor Accreditation
To earn NABP's Drug Distributor Accreditation, Second Source Rx had to demonstrate its commitment to preventing counterfeit drugs from entering the U.S. drug supply. - 4/24/2020
Hy-Vee sees sales of hair, beauty products surge
As more customers groom themselves at home amid the pandemic, Hy-Vee is seeing an increase in sales of hair coloring, hair trimmers, and nail care products. - 4/24/2020
NACDS, CRA urge California to enable pharmacist COVID-19 testing
CRA and NACDS are urging The California Department of Consumer Affairs to take action to empower pharmacists to order and provide COVID-19 tests as supplies become available. - 4/24/2020
Merck, Samsung Bioepis roll out Herceptin biosimilar
Ontruzant will be available at a 15% discount to the current list price of Herceptin, the company said. - 4/23/2020
Alembic launches generic Zithromax
Alembic’s azithromycin tablets are available in dosage strengths of 250 mg and 500 mg. - 4/22/2020
LexisNexis Risk Solutions launches COVID-19 data resource
LexisNexis Risk Solutions' COVID-19 Data Resource Center features heat maps with insights that identify at-risk populations and correlated gaps in provider coverage.